NDC-011

N/A

Report date: 2026/01/13 11:24:26

Base Information

Drug NameNDC-011
Drug Alias NameFixed-dose combination of Donepezil hydrochloride and Nebivolol hydrochlorideDonepezil/NebivololNDC-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonistsAcetylcholinesterase inhibitors
TargetsBeta-1 adrenergic receptorAcetylcholinesterase
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Nebivolol HydrochlorideDonepezil Hydrochloride
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDr. Noah Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesDr. Noah Biotech Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A